113 related articles for article (PubMed ID: 8891026)
1. Treatment of hand dermatosis: a comparative study of a topical glucocorticoid ointment vs solution occluded with a new thin hydrocolloid dressing.
Beitner H
Acta Derm Venereol; 1996 Sep; 76(5):408-9. PubMed ID: 8891026
[No Abstract] [Full Text] [Related]
2. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
[TBL] [Abstract][Full Text] [Related]
3. Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse.
van der Vleuten CJ; van Vlijmen-Willems IM; de Jong EM; van de Kerkhof PC
Arch Dermatol Res; 1999; 291(7-8):390-5. PubMed ID: 10482007
[TBL] [Abstract][Full Text] [Related]
4. Ranking of the antipsoriatic effect of various topical corticosteroids applied under a hydrocolloid dressing--skin-thickness, blood-flow and colour measurements compared to clinical assessments.
Broby-Johansen U; Karlsmark T; Petersen LJ; Serup J
Clin Exp Dermatol; 1990 Sep; 15(5):343-8. PubMed ID: 2225536
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric assessment of clearance and relapse characteristics in psoriasis vulgaris after treatment with weekly clobetasol lotion under hydrocolloid occlusion versus twice-daily clobetasol ointment.
Glade CP; van der Vleuten CJ; van Erp PE; van de Kerkhof PC
Skin Pharmacol Appl Skin Physiol; 2002; 15(2):92-9. PubMed ID: 11867965
[TBL] [Abstract][Full Text] [Related]
6. A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to clobetasol cream in palmo-plantar pustulosis.
Kragballe K; Larsen FG
Acta Derm Venereol; 1991; 71(6):540-2. PubMed ID: 1685841
[TBL] [Abstract][Full Text] [Related]
7. Keeping psoriasis under wraps.
Griffiths CE
J Dermatolog Treat; 2001 Sep; 12(3):133. PubMed ID: 12243702
[No Abstract] [Full Text] [Related]
8. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing.
Volden G
Acta Derm Venereol; 1992; 72(1):69-71. PubMed ID: 1350154
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of therapy-resistant atopic dermatitis with clobetasol propionate and a hydrocolloid occlusive dressing.
Volden G
Acta Derm Venereol Suppl (Stockh); 1992; 176():126-8. PubMed ID: 1476024
[TBL] [Abstract][Full Text] [Related]
10. Use of a hydrocolloid dressing in combination with a topical steroid in plaque psoriasis.
Theeuwes M; Bright R
Cutis; 1996 Jan; 57(1):48-50. PubMed ID: 8620686
[TBL] [Abstract][Full Text] [Related]
11. Clobetasol under hydrocolloid occlusion in psoriasis results in a complete block of proliferation and in a rebound of lesions following discontinuation.
Mommers JM; van Erp PE; van De Kerkhof PC
Dermatology; 1999; 199(4):323-7. PubMed ID: 10640842
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hyperkeratotic dermatitis of the palms. Sequential treatment with a keratolytic gel and corticosteroid ointment.
Baden HP
Arch Dermatol; 1974 Nov; 110(5):737-8. PubMed ID: 4424786
[No Abstract] [Full Text] [Related]
13. Clinical efficacy of two topical corticosteroids in the management of chronic hand eczema.
Gola M; D'Erme AM; Milanesi N
G Ital Dermatol Venereol; 2015 Jun; 150(3):293-6. PubMed ID: 25946672
[TBL] [Abstract][Full Text] [Related]
14. Lupus erythematosus profundus treated with clobetasol propionate under a hydrocolloid dressing.
Yell JA; Burge SM
Br J Dermatol; 1993 Jan; 128(1):103. PubMed ID: 8427814
[No Abstract] [Full Text] [Related]
15. Comparative atrophogenicity potential of medium and highly potent topical glucocorticoids in cream and ointment according to ultrasound analysis.
Kerscher MJ; Korting HC
Skin Pharmacol; 1992; 5(2):77-80. PubMed ID: 1637562
[TBL] [Abstract][Full Text] [Related]
16. Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream.
Rigopoulos D; Ioannides D; Prastitis N; Katsambas A
Acta Derm Venereol; 2002; 82(2):140. PubMed ID: 12125946
[No Abstract] [Full Text] [Related]
17. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial.
Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI
Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513
[TBL] [Abstract][Full Text] [Related]
18. Prolonged remission of urticaria pigmentosa following topical steroid therapy under hydrocolloid occlusion.
Sidhu S; Wakelin SH; Wojnarowska F
Clin Exp Dermatol; 1997 Nov; 22(6):302-3. PubMed ID: 9604463
[No Abstract] [Full Text] [Related]
19. Calcipotriol or clobetasol propionate occluded with a hydrocolloid dressing for treatment of nummular psoriasis.
Nielsen PG
Acta Derm Venereol; 1993 Oct; 73(5):394. PubMed ID: 7904413
[No Abstract] [Full Text] [Related]
20. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
Jacobson C; Cornell RC; Savin RC
Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
